New option listings for September 23rd include REX-Osprey DOGE ETF (DOJE) and REX-Osprey XRP ETF (XRPR). Option delistings effective September 23rd include GLOBAL X PROPTECH ETF (PTEC), PLYA Stock (PLYA), Olo Inc. (OLO), ISHARES EMERGENT FOOD AND AGTECH MULTISECTOR ETF (IVEG), iTeos Therapeutics (ITOS), IGM Biosciences Inc (IGMS), ISHARES CLOUD 5G AND TECH ETF (IDAT), GMS Inc (GMS), Global Blue Group Holding Ag (GB), Foot Locker, Inc. (FL), DURECT Corporation – Common Stock (DRRX), Dun & Bradstreet Holdings Inc (DNB), CARGO THERAPEUTICS, INC. (CRGX), ISHARES COMMODITY CURVE CARRY STRATEGY ETF (CCRV), Accelerate Diagnostics, Inc. (AXDXQ), Amedisys (AMED), Skechers U.S.A., Inc. (SKX), Walgreens Boots Alliance Inc (WBA), GLOBAL X WIND ENERGY ETF (WNDY), Xylo Technologies Ltd. (XYLO), and Y-mAbs Therapeutics, Inc (YMAB).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on YMAB:
- Y-Mabs Therapeutics Completes Merger with Perseus BidCo
- Y-Mabs Therapeutics’ Phase 2 Trial: A Potential Breakthrough for Neuroblastoma Treatment
- Y-mAbs Therapeutics Reports Q2 Earnings and Acquisition
- Y-mAbs Therapeutics reports Q2 EPS (7c), consensus (25c)
- Y-mAbs Therapeutics downgraded to Neutral from Buy at H.C. Wainwright